Publication Cover
Synthetic Communications
An International Journal for Rapid Communication of Synthetic Organic Chemistry
Volume 51, 2021 - Issue 13
140
Views
1
CrossRef citations to date
0
Altmetric
Articles

Synthesis of 2-aryl-1,2,4-triazol-3-one derivatives from β-nitroenamines

, , , , , , & show all
Pages 1956-1962 | Received 19 Jan 2021, Published online: 26 Apr 2021
 

Abstract

The preparation of representatively selected 2-aryl-4,5-disubstituted-1,2,4-triazol-3-ones from cyclic β-nitroenamines in four steps is provided, with an overall yield of 8–70%. The nitrazone to amidrazone conversion (third step) could not proceed in absence of LiBr catalyst, and the crucial role of this mild Lewis acid is emphasized. The last cyclization step required the boosting effect of N-methylimidazole and elevated reaction temperature, as well. This reliable synthesis is highly versatile as well, and it could furnish a chemical library of 2,4,5-trisubstituted-1,2,4-triazol-3-ones with potential pharmacological activities. The usefulness of the umpolung that is accompanied by a wide transformability of nitroenamines is highlighted.

Graphical Abstract

Acknowledgment

The authors are indebted to Mrs. Krisztina G. Kara for her great technical help. The financial support of the research grant IK-UK-2018 (University of Veterinary Medicine, Budapest, Hungary) is highly appreciated.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.